title: Caution warranted when defining contraindications in initiating β-blocker therapy--reply.
authors.affiliation: Division of Cardiology, Columbia University Medical Center, New York, New York2Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
authors.forename: Kumar
authors.initials: K
authors.lastname: Dharmarajan
authors.affiliation: Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut3Section of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut4Robert Wood Johnson Clinical Scholars Program, Section of Cardio.
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
mesh_terms: D000319:Adrenergic beta-Antagonists; D000075202:Contraindications; D004363:Drug Utilization / Q000706:statistics & numerical data*; D006333:Heart Failure / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans
chemical_list: D000319:Adrenergic beta-Antagonists